The World Health Organization is establishing an expert panel to set guidelines and standards on the ethical and safety issues of gene editing, the body has announced. This follows the recent revelation that a scientist in China claimed he had edited the genes of twin babies to make them HIV resistant.
Twin girls in China have allegedly been born after having their embryonic genetic code modified using CRISPR. Chinese researcher He Jiankui, from the Southern University of Science and Technology, claims to have turned off a gene called CCR5 to offer total protection against HIV, as well as smallpox and cholera.
The Code is an agreement between Government and the insurance industry – with a commitment from insurers to not ask customers about predictive genetic test results when applying for insurance.
Scientists at Dana-Farber Cancer Institute have solved a mystery that has lingered ever since the dangers of the drug first became apparent: how did the drug produce such severe fetal harm?
Americans are more likely to anticipate negative than positive effects from widespread use of gene-editing technology.
Prenatal gene therapy has been used to prevent acute neuronopathic Gaucher’s disease, however this approach is using viruses to deliver normal copies of genes.
The Nuffield Council on Bioethics has concluded that using gene editing tools on human embryos, sperm, or eggs for heritable gene editing could be ‘morally permissible’ in some cases.
CRISPR gene drives have been tested in laboratory mice for the first time, offering a way in which multiple genes in mice can be altered to model complex multigenic human diseases. Could this step eventually lead to the eradication of pest species or is the technology still too controversial?
Founded in 1790, the Patent Office aimed to put innovation and entrepreneurship within reach of every citizen. Now, 10 million patents later, critics say an out-of-touch system is doing the opposite.